Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni B Frisoni

Showing results (441-450 of 524) with videos related to

Pageof 53
Sort By:
Neuroimage|August 16, 2015
Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challengeDavid M Cash, Chris Frost, Leonardo O Iheme, et al.
Neuroimage. Clinical|July 15, 2022
The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflowLuigi Lorenzini, Silvia Ingala, Alle Meije Wink, et al.
The Lancet. Neurology|October 25, 2020
Amyloid-PET and <sup>18</sup>F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Javier Arbizu, Henryk Barthel, et al.
The Journal of Prevention of Alzheimer'S Disease|March 18, 2025
Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilitiesGiovanni B Frisoni, Federica Ribaldi, Gilles Allali, et al.
Brain Stimulation|July 17, 2010
Consensus paper: combining transcranial stimulation with neuroimagingHartwig R Siebner, Til O Bergmann, Sven Bestmann, et al.
Alzheimer'S Research & Therapy|June 17, 2024
Amyloid-PET imaging predicts functional decline in clinically normal individualsLisa Quenon, Lyduine E Collij, David Vállez Garcia, et al.
Journal of Alzheimer'S Disease : JAD|November 30, 2020
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid BiomarkersLinda J C van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M C van Leijsen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Harald Hampel, Howard H Feldman, et al.
Neurobiology of Aging|April 30, 2017
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG studyClaudio Babiloni, Claudio Del Percio, Roberta Lizio, et al.
Geroscience|June 11, 2025
The compensatory effect of education as revealed by resting-state electroencephalographic alpha rhythms in patients with dementia due to Parkinson's disease: findings from an exploratory studySusanna Lopez, Claudio Del Percio, Roberta Lizio, et al.
Pageof 53

Showing results (441-450 of 524) with videos related to

Sort By:
Pageof 53
Neuroimage|August 16, 2015
Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challengeDavid M Cash, Chris Frost, Leonardo O Iheme, et al.
Neuroimage. Clinical|July 15, 2022
The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflowLuigi Lorenzini, Silvia Ingala, Alle Meije Wink, et al.
The Lancet. Neurology|October 25, 2020
Amyloid-PET and <sup>18</sup>F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Javier Arbizu, Henryk Barthel, et al.
The Journal of Prevention of Alzheimer'S Disease|March 18, 2025
Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilitiesGiovanni B Frisoni, Federica Ribaldi, Gilles Allali, et al.
Brain Stimulation|July 17, 2010
Consensus paper: combining transcranial stimulation with neuroimagingHartwig R Siebner, Til O Bergmann, Sven Bestmann, et al.
Alzheimer'S Research & Therapy|June 17, 2024
Amyloid-PET imaging predicts functional decline in clinically normal individualsLisa Quenon, Lyduine E Collij, David Vállez Garcia, et al.
Journal of Alzheimer'S Disease : JAD|November 30, 2020
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid BiomarkersLinda J C van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M C van Leijsen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Harald Hampel, Howard H Feldman, et al.
Neurobiology of Aging|April 30, 2017
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG studyClaudio Babiloni, Claudio Del Percio, Roberta Lizio, et al.
Geroscience|June 11, 2025
The compensatory effect of education as revealed by resting-state electroencephalographic alpha rhythms in patients with dementia due to Parkinson's disease: findings from an exploratory studySusanna Lopez, Claudio Del Percio, Roberta Lizio, et al.
Pageof 53